vs
National Storage Affiliates Trust（NSA）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是National Storage Affiliates Trust的1.1倍（$207.3M vs $187.0M），National Storage Affiliates Trust净利率更高（12.2% vs -62.0%，领先74.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -1.6%），National Storage Affiliates Trust自由现金流更多（$299.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -2.4%）
National Storage Affiliates Trust是一家总部位于美国的房地产投资信托，专注于自助仓储资产，在美国数十个州持有、运营及收购自助仓储设施，为居民和商业客户提供安全的存储服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
NSA vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $187.0M | $207.3M |
| 净利润 | $22.9M | $-128.6M |
| 毛利率 | 72.5% | — |
| 营业利润率 | 20.2% | -54.7% |
| 净利率 | 12.2% | -62.0% |
| 营收同比 | -1.6% | 25.9% |
| 净利润同比 | 36.8% | 3.5% |
| 每股收益（稀释后） | $0.23 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $187.0M | $207.3M | ||
| Q3 25 | $188.7M | $159.9M | ||
| Q2 25 | $188.8M | $166.5M | ||
| Q1 25 | $188.4M | $139.3M | ||
| Q4 24 | $190.1M | $164.6M | ||
| Q3 24 | $193.6M | $139.5M | ||
| Q2 24 | $190.4M | $147.0M | ||
| Q1 24 | $196.1M | $108.8M |
| Q4 25 | $22.9M | $-128.6M | ||
| Q3 25 | $18.4M | $-180.4M | ||
| Q2 25 | $19.5M | $-115.0M | ||
| Q1 25 | $13.0M | $-151.1M | ||
| Q4 24 | $16.7M | $-133.2M | ||
| Q3 24 | $18.7M | $-133.5M | ||
| Q2 24 | $17.1M | $-131.6M | ||
| Q1 24 | $59.0M | $-170.7M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 70.7% | — | ||
| Q2 25 | 70.5% | — | ||
| Q1 25 | 70.7% | — | ||
| Q4 24 | 72.5% | — | ||
| Q3 24 | 72.8% | — | ||
| Q2 24 | 72.6% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | 20.2% | -54.7% | ||
| Q3 25 | 15.8% | -106.9% | ||
| Q2 25 | 16.5% | -64.8% | ||
| Q1 25 | 11.0% | -102.6% | ||
| Q4 24 | 14.5% | -74.3% | ||
| Q3 24 | 15.8% | -94.6% | ||
| Q2 24 | 17.2% | -79.1% | ||
| Q1 24 | 48.9% | -151.9% |
| Q4 25 | 12.2% | -62.0% | ||
| Q3 25 | 9.8% | -112.8% | ||
| Q2 25 | 10.3% | -69.0% | ||
| Q1 25 | 6.9% | -108.5% | ||
| Q4 24 | 8.8% | -80.9% | ||
| Q3 24 | 9.7% | -95.7% | ||
| Q2 24 | 9.0% | -89.5% | ||
| Q1 24 | 30.1% | -156.8% |
| Q4 25 | $0.23 | $-1.28 | ||
| Q3 25 | $0.17 | $-1.81 | ||
| Q2 25 | $0.19 | $-1.17 | ||
| Q1 25 | $0.10 | $-1.57 | ||
| Q4 24 | $0.19 | $-1.34 | ||
| Q3 24 | $0.18 | $-1.40 | ||
| Q2 24 | $0.16 | $-1.52 | ||
| Q1 24 | $0.65 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $946.0M | $-80.0M |
| 总资产 | $5.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $23.3M | $421.0M | ||
| Q3 25 | $26.3M | $202.5M | ||
| Q2 25 | $26.1M | $176.3M | ||
| Q1 25 | $19.3M | $127.1M | ||
| Q4 24 | $50.4M | $174.0M | ||
| Q3 24 | $69.9M | $150.6M | ||
| Q2 24 | $59.0M | $480.7M | ||
| Q1 24 | $64.2M | $112.3M |
| Q4 25 | $946.0M | $-80.0M | ||
| Q3 25 | $973.1M | $9.2M | ||
| Q2 25 | $1.0B | $151.3M | ||
| Q1 25 | $1.0B | $144.2M | ||
| Q4 24 | $1.1B | $255.0M | ||
| Q3 24 | $986.9M | $346.8M | ||
| Q2 24 | $1.2B | $432.4M | ||
| Q1 24 | $1.3B | $140.3M |
| Q4 25 | $5.1B | $1.5B | ||
| Q3 25 | $5.1B | $1.2B | ||
| Q2 25 | $5.2B | $1.3B | ||
| Q1 25 | $5.3B | $1.3B | ||
| Q4 24 | $5.4B | $1.5B | ||
| Q3 24 | $5.4B | $1.5B | ||
| Q2 24 | $5.3B | $1.6B | ||
| Q1 24 | $5.4B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $338.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $299.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 160.3% | -48.6% |
| 资本支出强度资本支出/营收 | 20.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 14.79× | — |
| 过去12个月自由现金流最近4个季度 | $541.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $338.5M | $-99.8M | ||
| Q3 25 | $100.2M | $-91.4M | ||
| Q2 25 | $79.9M | $-108.3M | ||
| Q1 25 | $85.6M | $-166.5M | ||
| Q4 24 | $363.1M | $-79.3M | ||
| Q3 24 | $105.7M | $-67.0M | ||
| Q2 24 | $83.2M | $-77.0M | ||
| Q1 24 | $94.0M | $-190.7M |
| Q4 25 | $299.8M | $-100.8M | ||
| Q3 25 | $88.0M | $-92.7M | ||
| Q2 25 | $73.8M | $-110.7M | ||
| Q1 25 | $79.9M | $-167.8M | ||
| Q4 24 | $344.4M | $-79.5M | ||
| Q3 24 | $101.8M | $-68.6M | ||
| Q2 24 | $79.5M | $-79.0M | ||
| Q1 24 | $88.6M | $-193.9M |
| Q4 25 | 160.3% | -48.6% | ||
| Q3 25 | 46.6% | -58.0% | ||
| Q2 25 | 39.1% | -66.5% | ||
| Q1 25 | 42.4% | -120.5% | ||
| Q4 24 | 181.2% | -48.3% | ||
| Q3 24 | 52.6% | -49.2% | ||
| Q2 24 | 41.7% | -53.7% | ||
| Q1 24 | 45.2% | -178.2% |
| Q4 25 | 20.7% | 0.5% | ||
| Q3 25 | 6.5% | 0.8% | ||
| Q2 25 | 3.2% | 1.5% | ||
| Q1 25 | 3.0% | 1.0% | ||
| Q4 24 | 9.8% | 0.1% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 1.9% | 1.4% | ||
| Q1 24 | 2.7% | 3.0% |
| Q4 25 | 14.79× | — | ||
| Q3 25 | 5.44× | — | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 6.59× | — | ||
| Q4 24 | 21.70× | — | ||
| Q3 24 | 5.65× | — | ||
| Q2 24 | 4.88× | — | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NSA
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
